Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jozef, Dodulík"'
Autor:
Jiří Plášek, Jozef Dodulík, Petr Gai, Barbora Hrstková, Jan Škrha, Lukáš Zlatohlávek, Renata Vlasáková, Peter Danko, Petr Ondráček, Eva Čubová, Bronislav Čapek, Marie Kollárová, Tomáš Fürst, Jan Václavík
Publikováno v:
Infectious Disease Reports, Vol 16, Iss 1, Pp 105-115 (2024)
SARS-CoV-2 respiratory infection is associated with significant morbidity and mortality in hospitalized patients. We aimed to assess the risk factors for hospital mortality in non-vaccinated patients during the 2021 spring wave in the Czech Republic.
Externí odkaz:
https://doaj.org/article/3027b2dcafa24066a55d464013751080
Autor:
Jiří Plášek, Jozef Dodulík, Marie Lazárová, David Stejskal, Zdeněk Švagera, Nela Chobolová, Patrik Šulc, Lukáš Evin, Dana Purová, Jan Václavík
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
Externí odkaz:
https://doaj.org/article/41cff616fe2a4af4bc4c0140f5111329
Autor:
Jiří Plášek, Jozef Dodulík, Marie Lazárová, David Stejskal, Zdeněk Švagera, Nela Chobolová, Patrik Šulc, Lukáš Evin, Dana Purová, Jan Václavík
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2024)
BackgroundSecretoneurin (SN) is a neuropeptide with potential utility as a biomarker of cardiovascular episodes. The main effect of SN is mediated through its inhibition of calmodulin-dependent kinase II (CaMKII), which influences calcium handling. W
Externí odkaz:
https://doaj.org/article/ebb2084a266d449ea66ebac0596cc0fe
Publikováno v:
Vnitřní lékařství. 68:154-158
Chronic heart failure (HF), like any chronic disease, is a medical and socioeconomic burden. The number of patients with HF is increasing and our effort is to apply the most effective way of care in practice, preferably together with using telemedici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e65ff073ee87e34bf97017eba01bdf4
https://doi.org/10.36290/vnl.2022.031
https://doi.org/10.36290/vnl.2022.031
Autor:
Jiří Plášek, Marie Lazárová, Jozef Dodulík, Patrik Šulc, David Stejskal, Zdeněk Švagera, František Všianský, Jan Václavík
Publikováno v:
Journal of Clinical Medicine. 11:7191
Secretoneurin (SN) is a 33 amino-acid evolutionary conserved neuropeptide from the chromogranin peptide family. SN’s main effects may be cardioprotective and are believed to be mediated through its inhibition of calmodulin-dependent kinase II (CaMK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54741c16733bed57667b392eaab70d3e
https://doi.org/10.3390/jcm11237191
https://doi.org/10.3390/jcm11237191